Launching the New Modality Support website! New Modality Support is hosted by GU Ventures with the mission to support commercial development of research projects in the therapeutic oligonucleotide and advanced therapies space. This is an optional, added value package to projects running in OligoNova Hub / SciLifeLab Drug Discovery & Development and CCRM Nordic. Have a look at the website and contact us for more information!
🚀 New Website Launch! 🚀 New Modality Support (NMS) — a collaboration between Sahlgrenska Academy at University of Gothenburg, Sahlgrenska Universitetssjukhuset and GU Ventures, was established recently, with the mission to support the commercial development of research projects within the national drug development initiatives OligoNova Hub and CCRM Nordic. We’re excited to announce the launch of our brand-new website: https://lnkd.in/dKa2U2vi Check out our landing page in the video below and visit us for the full experience. Explore our focus areas and future plans by browsing through our pages. We feature our constellation members and a selection of esteemed collaborators. Thank you for your support; we look forward to continuing our work together! BioVentureHub, ATMP Sweden, CCRM, FUHS - Föreningen Universitetsholdingbolag i Sverige, GoCo Health Innovation City, Invest in Gothenburg, Lif - de forskande läkemedelsföretagen (The Swedish Association of the Pharmaceutical Industry LIF), NorthX Biologics, SciLifeLab, SciLifeLab Drug Discovery & Development, SwedenBIO, Testa Center, Västra Götalandsregionen, WCMTM University of Gothenburg